Phase Ii Study of Nilotinib in Melanoma Harboring Kit Alterations Following Progression or Intolerance to Prior Kit Inhibition
2014; Elsevier BV; Volume: 25; Linguagem: Inglês
10.1093/annonc/mdu344.28
ISSN1569-8041
AutoresRichard D. Carvajal, Donald P. Lawrence, Jeffrey S. Weber, Thomas F. Gajewski, René González, Jose Lutzky, Steven O’Day, Omid Hamid, Jedd D. Wolchok, Paul B. Chapman, Ryan J. Sullivan, Jerrold B. Teitcher, Cristina R. Antonescu, Michael C. Heinrich, Boris C. Bastian, Christopher L. Corless, Anita Giobbie‐Hurder, Jonathan A. Fletcher, F. Stephen Hodi,
Tópico(s)Eosinophilic Disorders and Syndromes
Referência(s)